The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
Nom du journal : Clin Breast Cancer
Année : 2024
Volume : 24
Page de départ : 421-430.e3
